Novartis Pledges 10-Year Commitment to Health Equity Collaboration
July 21st 2021Novartis and the Novartis US Foundation have launched a 10-year commitment to co-create programs “that address the root causes of systemic disparities in health outcomes and create greater diversity, equity and inclusion across the research and development ecosystem.”
Industry Groups Call for Advanced Therapies to be Exempt from EU GMO Legislation
May 25th 2021The European Commission’s Genetically Modified Organism (GMO) legislation hurts Europe’s ability to attract clinical trials and delays patient access to transformative medicines, say European industry associations.